{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-010368","form_type":"8-K","ticker":"AAWH","cik":"0001756390","company_name":"Ascend Wellness Holdings, Inc.","filed_at":"2024-03-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.411475+00:00","generated_at":"2026-06-04T23:08:31.136522+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Q4 net revenue $140M (+25% YoY), adjusted EBITDA $32M; first full year positive ops cash flow","bullets":["Q4 2023 net revenue $140.2M, up 25.0% YoY; full year net revenue $518.6M, up 27.8% YoY.","Net loss narrowed to $48.2M in FY 2023 from $80.9M in FY 2022; Q4 net loss $19.3M.","Adjusted EBITDA Q4 $32.4M (+14.8% YoY); full year $106.5M (+14.3% YoY).","First full year of positive cash from operations ($54.5M) and positive free cash flow ($30.3M, excl. $20.8M ERTC).","Ended Q4 with $72.5M cash; net debt $236.2M; opened 6 dispensaries in 2023, total now 35."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-010368","json":"https://secwatch.observer/filing/0001628280-24-010368.json","markdown":"https://secwatch.observer/filing/0001628280-24-010368.md","text":"https://secwatch.observer/filing/0001628280-24-010368.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/0001628280-24-010368-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/aawh-20240312.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T23:08:31.136522+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38c9e5c0251f61d4bc7c5f7c516844cb3370805b","claim":"Ascend Wellness Holdings, Inc. reported FY2023 results: net income $48.2 million loss.","evidence_excerpt":"FY 2023: Net revenue increased 27.8% year-over year to $518.6 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/0001628280-24-010368-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY2023"},{"label":"Net income","value":"$48.2 million loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"38c9e5c0251f61d4bc7c5f7c516844cb3370805b","claim":"Ascend Wellness Holdings, Inc. reported FY2023 results: net income $48.2 million loss.","evidence_excerpt":"FY 2023: Net loss of $48.2 million compared to net loss of $80.9 million for FY 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/0001628280-24-010368-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"FY2023"},{"label":"Net income","value":"$48.2 million loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e159a844aab1bb4820c6ec4b4fa7569013bc54eb","claim":"Ascend Wellness Holdings, Inc. reported Q4 FY2023 results: net income $19.3 million loss.","evidence_excerpt":"Q4 2023: Net revenue, which excludes intercompany sale of wholesale products, decreased 0.8% quarter-over-quarter to $140.2 million, and increased 25.0% year-over year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/0001628280-24-010368-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q4 FY2023"},{"label":"Net income","value":"$19.3 million loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"e159a844aab1bb4820c6ec4b4fa7569013bc54eb","claim":"Ascend Wellness Holdings, Inc. reported Q4 FY2023 results: net income $19.3 million loss.","evidence_excerpt":"Q4 2023: Net loss of $19.3 million compared to net loss of $15.1 million in Q4 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1756390/000162828024010368/0001628280-24-010368-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q4 FY2023"},{"label":"Net income","value":"$19.3 million loss"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}